NCT03951194

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Perimenopausal Women

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Genesis Athens Clinic · Academic / Other
• Sex: Female
• Age: 40 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Autologous PRP intra ovarian infusion may improve ovarian response and women's hormonal profile and may promote folliculogenesis in perimenopausal women.

Detailed description

This triple-blind Randomized Controlled Trial (RCT) aims to investigate the effectiveness of autologous PRP intra ovarian infusion on improving ovarian tissue functionality and hormonal profile of perimenopausal women. PRP is blood plasma prepared from fresh whole blood that has been enriched with platelets. It is collected from peripheral veins and contains several growth factors such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), platelet derived growth factor (PDGF), transforming growth factor (TGF) and other cytokines all of which stimulate tissue proliferation and growth. PRP has been employed in several medical conditions in Orthopedics, Dermatology, and Ophthalmology for wound healing. It's efficacy in ovarian rejuvenation and reactivation and endometrial regeneration has not been fully elucidated. This study aims to investigate the effect of autologous PRP intra ovarian infusion on improving ovarian tissue functionality in perimenopausal women.

Conditions

• Infertility, Female
• Perimenopausal Disorder
• Menstrual Cycle Abnormal

Interventions

Type	Name	Description
BIOLOGICAL	Autologous Platelet Rich Plasma (PRP) intra ovarian infusion	Autologous PRP intra ovarian infusion
OTHER	Placebo: Autologous Platelet Free Plasma (PFP) intra ovarian infusion	Autologous PFP intra ovarian infusion

Timeline

• Start date: 2019-06-13
• Primary completion: 2025-01-30
• Completion: 2025-07-30
• First posted: 2019-05-15
• Last updated: 2024-12-24

Locations

1 site across 1 country: Greece